CIK 0001540159
- Non-accelerated filer
- Smaller reporting company
Edesa Biotech, Inc.
Sign in to watch- Ticker
- EDSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- Phone
- +1 905-475-1234
- Business address
- C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
- Former names
- Stellar Biotechnologies, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale 10% owner sold 297,474 shares at an average $2.65 ($787,716)
- 4 Grant or award President acquired 4,239 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 8,888 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 456,524 shares (grant or award)
- 4 Open-market buy Chief Executive Officer bought 20,000 shares at $1.60 ($32,078)
- 4 Open-market buy President bought 3,000 shares at $1.49 ($4,483)
- 4 Open-market buy President bought 3,000 shares at $1.61 ($4,817)
Page 5 of 14 · 261 filings